Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)
Clinical trial NCT06434350 · RECRUITING
Trial details
- NCT number
- NCT06434350
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2027-09-24
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.